Stockholm - Delayed Quote SEK

Lipigon Pharmaceuticals AB (publ) (LPGO.ST)

Compare
0.1264
+0.0082
+(6.94%)
At close: 4:56:28 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
8,970
16,407
--
3,180
4,278
Operating Expense
31,258
28,779
37,742
44,371
12,102
Operating Income
-22,288
-12,372
-37,742
-41,191
-7,824
Net Non Operating Interest Income Expense
176
243
37
78
7
Pretax Income
-22,110
-12,128
-37,705
-41,113
-8,068
Net Income Common Stockholders
-22,110
-12,128
-37,705
-41,113
-8,068
Diluted NI Available to Com Stockholders
-22,110
-12,128
-37,705
-41,113
-8,068
Basic EPS
-0.24
-0.19
-2.12
-3.35
-0.64
Diluted EPS
-0.24
-0.19
-2.12
-3.35
-0.64
Basic Average Shares
107,771.1360
64,121.1850
17,790.7110
12,271.1170
12,526.0110
Diluted Average Shares
107,771.1360
64,121.1850
17,790.7110
12,271.1170
12,526.0110
Total Operating Income as Reported
-22,286
-12,371
-37,742
-41,191
-7,824
Total Expenses
31,258
28,779
37,742
44,371
12,102
Net Income from Continuing & Discontinued Operation
-22,110
-12,128
-37,705
-41,113
-8,068
Normalized Income
-22,110
-12,128
-37,705
-41,113
-7,817
Interest Income
238
246
37
83
10
Interest Expense
62
3
--
5
3
Net Interest Income
176
243
37
78
7
EBIT
-22,048
-12,125
-37,705
-41,108
-8,065
EBITDA
-22,024
-12,101
-37,681
-41,085
-8,065
Reconciled Depreciation
24
24
24
23
--
Net Income from Continuing Operation Net Minority Interest
-22,110
-12,128
-37,705
-41,113
-8,068
Total Unusual Items Excluding Goodwill
--
--
--
--
-251
Total Unusual Items
--
--
--
--
-251
Normalized EBITDA
-22,024
-12,101
-37,681
-41,085
-7,814
12/31/2020 - 3/1/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CHOSA.ST CHOSA Oncology AB
0.6680
-4.57%
 
LIDDS.ST LIDDS AB (publ)
0.0600
+55.44%
 
SIMRIS-B.ST Simris Group AB (PUBL)
0.1105
-1.34%
 
2CUREX.ST 2cureX AB (publ)
0.3500
-6.17%
 
FLUI.ST Fluicell AB (publ)
11.66
-14.89%
 
STABL.ST Stayble Therapeutics AB (publ)
0.4480
-10.40%
 
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
 
IMMU.ST Mendus AB (publ)
5.70
+2.46%
 
CANTA.ST Cantargia AB (publ)
1.2950
-2.04%
 
ALZCUR.ST AlzeCure Pharma AB (publ)
2.6100
+9.66%